Sagent Pharmaceuticals, Inc. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sagent Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sagent Pharmaceuticals, Inc. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 28 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 21.43 | 2,021 | 43,310 | 33,011 | 35 K to 33 K (-5.77 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 21.75 | 423 | 9,200 | 16,758 | 17.2 K to 16.8 K (-2.46 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Payment of Exercise | F | 21.84 | 566 | 12,361 | 17,181 | 17.7 K to 17.2 K (-3.19 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 21.75 | 955 | 20,771 | 679,267 | 680.2 K to 679.3 K (-0.14 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Payment of Exercise | F | 21.84 | 1,279 | 27,933 | 680,222 | 681.5 K to 680.2 K (-0.19 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Corporate VP, Sales | Payment of Exercise | F | 21.75 | 290 | 6,308 | 25,413 | 25.7 K to 25.4 K (-1.13 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Corporate VP, Sales | Payment of Exercise | F | 21.84 | 388 | 8,474 | 25,703 | 26.1 K to 25.7 K (-1.49 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 567 | 0 | 1,134 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | M | 0.00 | 759 | 0 | 2,280 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 567 | 0 | 34,652 | 34.1 K to 34.7 K (+1.66 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Buy | M | 0.00 | 759 | 0 | 34,085 | 33.3 K to 34.1 K (+2.28 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 567 | 0 | 1,134 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | M | 0.00 | 759 | 0 | 2,280 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 567 | 0 | 1,893 | 1.3 K to 1.9 K (+42.76 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Buy | M | 0.00 | 759 | 0 | 1,326 | 567 to 1.3 K (+133.86 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 567 | 0 | 1,134 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | M | 0.00 | 759 | 0 | 2,280 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 567 | 0 | 6,996 | 6.4 K to 7 K (+8.82 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Buy | M | 0.00 | 759 | 0 | 6,429 | 5.7 K to 6.4 K (+13.39 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 567 | 0 | 1,134 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | M | 0.00 | 759 | 0 | 2,280 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 567 | 0 | 1,893 | 1.3 K to 1.9 K (+42.76 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Buy | M | 0.00 | 759 | 0 | 1,326 | 567 to 1.3 K (+133.86 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | M | 4.23 | 20,000 | 84,600 | 0 | |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 21.75 | 441 | 9,592 | 35,032 | 35.5 K to 35 K (-1.24 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Payment of Exercise | F | 21.84 | 590 | 12,886 | 35,473 | 36.1 K to 35.5 K (-1.64 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 21.78 | 3,894 | 84,811 | 36,063 | 40 K to 36.1 K (-9.75 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Buy | M | 4.23 | 20,000 | 84,600 | 39,957 | 20 K to 40 K (+100.22 %) |
| Feb 24 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Sell | S | 22.05 | 4,638 | 102,268 | 19,957 | 24.6 K to 20 K (-18.86 %) |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | FEKETE MICHAEL | Director | Option Exercise | A | 0.00 | 3,720 | 0 | 3,720 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | KUNG FRANK | Director | Option Exercise | A | 0.00 | 3,720 | 0 | 3,720 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Krizman Anthony | Director | Option Exercise | A | 0.00 | 3,720 | 0 | 3,720 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | FLANAGAN ROBERT J | Director | Option Exercise | A | 0.00 | 3,720 | 0 | 3,720 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Behrens Mary Taylor | Director | Option Exercise | A | 0.00 | 3,720 | 0 | 3,720 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Greve Jeffrey W. | Vice President, Con ... | Option Exercise | A | 20.16 | 8,865 | 178,718 | 8,865 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Corporate VP, Sales | Option Exercise | A | 20.16 | 8,865 | 178,718 | 8,865 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Drake Lorin | Corporate VP, Sales | Grant | A | 0.00 | 4,960 | 0 | 26,091 | 21.1 K to 26.1 K (+23.47 %) |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Option Exercise | A | 20.16 | 8,865 | 178,718 | 8,865 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Patterson Albert | EVP, Nat. Accts and ... | Grant | A | 0.00 | 4,960 | 0 | 38,333 | 33.4 K to 38.3 K (+14.86 %) |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Option Exercise | A | 20.16 | 10,638 | 214,462 | 10,638 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Logerfo Michael | Chief Legal Officer | Grant | A | 0.00 | 5,952 | 0 | 24,595 | 18.6 K to 24.6 K (+31.93 %) |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Option Exercise | A | 20.16 | 11,968 | 241,275 | 11,968 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | HUSSEY JAMES M | President | Grant | A | 0.00 | 6,696 | 0 | 6,696 | 0 to 6.7 K |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Option Exercise | A | 20.16 | 10,638 | 214,462 | 10,638 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | Singer Jonathon M | EVP and CFO | Grant | A | 0.00 | 5,952 | 0 | 17,747 | 11.8 K to 17.7 K (+50.46 %) |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Option Exercise | A | 20.16 | 23,936 | 482,550 | 23,936 | |
| Feb 19 2014 | SGNT | Sagent Pharmaceuti ... | YORDON JEFFREY | Chief Executive Off ... | Grant | A | 0.00 | 13,393 | 0 | 681,501 | 668.1 K to 681.5 K (+2.00 %) |